EP. 1: The Targeted Pulse: Cancer Research Slowed by Funding Freezes and the FDA Takes Forward Steps
The FDA advances in multiple cancer types, and researchers assess potential impacts of funding freezes on cancer research.
EP. 2: The Targeted Pulse: New Trial Evaluating Iadademstat/Azacitidine in MDS and Positive Trends in HNSCC
Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.
EP. 3: The Targeted Pulse: Immunotherapy’s Success in Triple-Negative Breast Cancer and Key FDA Actions to Know
This week's Targeted Pulse highlights immunotherapy’s success in triple-negative breast cancer and key FDA actions shaping treatment advancements.
